2y5l

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (10:45, 20 December 2023) (edit) (undo)
 
(7 intermediate revisions not shown.)
Line 1: Line 1:
-
[[Image:2y5l.png|left|200px]]
 
-
{{STRUCTURE_2y5l| PDB=2y5l | SCENE= }}
+
==orally active aminopyridines as inhibitors of tetrameric fructose 1,6- bisphosphatase==
 +
<StructureSection load='2y5l' size='340' side='right'caption='[[2y5l]], [[Resolution|resolution]] 2.20&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[2y5l]] is a 8 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2Y5L OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2Y5L FirstGlance]. <br>
 +
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.2&#8491;</td></tr>
 +
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=RO8:N-{[(2Z)-5-BROMO-1,3-THIAZOL-2(3H)-YLIDENE]CARBAMOYL}-3-CHLOROBENZENESULFONAMIDE'>RO8</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2y5l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2y5l OCA], [https://pdbe.org/2y5l PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2y5l RCSB], [https://www.ebi.ac.uk/pdbsum/2y5l PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2y5l ProSAT]</span></td></tr>
 +
</table>
 +
== Disease ==
 +
[https://www.uniprot.org/uniprot/F16P1_HUMAN F16P1_HUMAN] Defects in FBP1 are the cause of fructose-1,6-bisphosphatase deficiency (FBPD) [MIM:[https://omim.org/entry/229700 229700]. FBPD is inherited as an autosomal recessive disorder mainly in the liver and causes life-threatening episodes of hypoglycemia and metabolic acidosis (lactacidemia) in newborn infants or young children.<ref>PMID:9382095</ref> <ref>PMID:12126934</ref>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/F16P1_HUMAN F16P1_HUMAN]
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
A novel sulfonylureido pyridine series exemplified by compound 19 yielded potent inhibitors of FBPase showing significant glucose reduction and modest glycogen lowering in the acute db/db mouse model for Type-2 diabetes. Our inhibitors occupy the allosteric binding site and also extend into the dyad interface region of tetrameric FBPase.
-
===ORALLY ACTIVE AMINOPYRIDINES AS INHIBITORS OF TETRAMERIC FRUCTOSE 1,6-BISPHOSPHATASE===
+
Orally active aminopyridines as inhibitors of tetrameric fructose-1,6-bisphosphatase.,Hebeisen P, Haap W, Kuhn B, Mohr P, Wessel HP, Zutter U, Kirchner S, Ruf A, Benz J, Joseph C, Alvarez-Sanchez R, Gubler M, Schott B, Benardeau A, Tozzo E, Kitas E Bioorg Med Chem Lett. 2011 Jun 1;21(11):3237-42. Epub 2011 Apr 20. PMID:21550236<ref>PMID:21550236</ref>
-
{{ABSTRACT_PUBMED_21550236}}
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-
 
+
</div>
-
==About this Structure==
+
<div class="pdbe-citations 2y5l" style="background-color:#fffaf0;"></div>
-
[[2y5l]] is a 8 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2Y5L OCA].
+
==See Also==
==See Also==
-
*[[Fructose-1%2C6-bisphosphatase|Fructose-1%2C6-bisphosphatase]]
+
*[[Fructose-1%2C6-bisphosphatase 3D structures|Fructose-1%2C6-bisphosphatase 3D structures]]
-
 
+
== References ==
-
==Reference==
+
<references/>
-
<ref group="xtra">PMID:021550236</ref><references group="xtra"/>
+
__TOC__
-
[[Category: Fructose-bisphosphatase]]
+
</StructureSection>
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
-
[[Category: Alvarez-Sanchez, R.]]
+
[[Category: Large Structures]]
-
[[Category: Benardeau, A.]]
+
[[Category: Alvarez-sanchez r]]
-
[[Category: Benz, J.]]
+
[[Category: Benardeau a]]
-
[[Category: Gubler, M.]]
+
[[Category: Benz j]]
-
[[Category: Haap, W.]]
+
[[Category: Gubler m]]
-
[[Category: Hebeisen, P.]]
+
[[Category: Haap w]]
-
[[Category: Joseph, C.]]
+
[[Category: Hebeisen p]]
-
[[Category: Kirchner, S.]]
+
[[Category: Joseph c]]
-
[[Category: Kitas, E.]]
+
[[Category: Kirchner s]]
-
[[Category: Kuhn, B.]]
+
[[Category: Kitas e]]
-
[[Category: Mohr, P.]]
+
[[Category: Kuhn b]]
-
[[Category: Ruf, A.]]
+
[[Category: Mohr p]]
-
[[Category: Schott, B.]]
+
[[Category: Ruf a]]
-
[[Category: Tozzo, E.]]
+
[[Category: Schott b]]
-
[[Category: Wessel, H P.]]
+
[[Category: Tozzo e]]
-
[[Category: Zutter, U.]]
+
[[Category: Wessel hp]]
-
[[Category: Hydrolase]]
+
[[Category: Zutter u]]

Current revision

orally active aminopyridines as inhibitors of tetrameric fructose 1,6- bisphosphatase

PDB ID 2y5l

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2y5l"
Personal tools